Cytochroma
Latest round
- Series C
Last raised
- Jul 2008
Total raised
- $59M
Investors
- 13
About Cytochroma
Cytochroma is a clinical stage specialty pharmaceutical company. It designs, develops, and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD).
Who invested in Cytochroma
13 investors across 4 rounds
See all investors in Cytochroma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cytochroma
Who invested in Cytochroma?
Cytochroma has 13 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cytochroma raised?
Cytochroma has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Cytochroma last raise money?
Cytochroma's most recent round on record is a Series C, in Jul 2008.
What does Cytochroma do?
Cytochroma is a clinical stage specialty pharmaceutical company.
Where is Cytochroma headquartered?
Cytochroma is headquartered in Markham, Canada.
Which VCs invest in companies like Cytochroma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Cytochroma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Cytochroma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.